JP2016512259A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512259A5
JP2016512259A5 JP2016500760A JP2016500760A JP2016512259A5 JP 2016512259 A5 JP2016512259 A5 JP 2016512259A5 JP 2016500760 A JP2016500760 A JP 2016500760A JP 2016500760 A JP2016500760 A JP 2016500760A JP 2016512259 A5 JP2016512259 A5 JP 2016512259A5
Authority
JP
Japan
Prior art keywords
methyl
chlorophenyl
difluoromethoxy
methoxypyridin
triazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500760A
Other languages
English (en)
Japanese (ja)
Other versions
JP6282721B2 (ja
JP2016512259A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021426 external-priority patent/WO2014158998A1/en
Publication of JP2016512259A publication Critical patent/JP2016512259A/ja
Publication of JP2016512259A5 publication Critical patent/JP2016512259A5/ja
Application granted granted Critical
Publication of JP6282721B2 publication Critical patent/JP6282721B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500760A 2013-03-14 2014-03-06 Pde4阻害剤としての置換ピリジン及びピラジン化合物 Active JP6282721B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786288P 2013-03-14 2013-03-14
US61/786,288 2013-03-14
PCT/US2014/021426 WO2014158998A1 (en) 2013-03-14 2014-03-06 Substituted pyridine and pyrazine compounds as pde4 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018009464A Division JP6505878B2 (ja) 2013-03-14 2018-01-24 Pde4阻害剤としての置換ピリジン及びピラジン化合物

Publications (3)

Publication Number Publication Date
JP2016512259A JP2016512259A (ja) 2016-04-25
JP2016512259A5 true JP2016512259A5 (cg-RX-API-DMAC7.html) 2017-04-06
JP6282721B2 JP6282721B2 (ja) 2018-02-21

Family

ID=51530139

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016500760A Active JP6282721B2 (ja) 2013-03-14 2014-03-06 Pde4阻害剤としての置換ピリジン及びピラジン化合物
JP2018009464A Active JP6505878B2 (ja) 2013-03-14 2018-01-24 Pde4阻害剤としての置換ピリジン及びピラジン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018009464A Active JP6505878B2 (ja) 2013-03-14 2018-01-24 Pde4阻害剤としての置換ピリジン及びピラジン化合物

Country Status (17)

Country Link
US (8) US20160009691A1 (cg-RX-API-DMAC7.html)
EP (2) EP2970212B1 (cg-RX-API-DMAC7.html)
JP (2) JP6282721B2 (cg-RX-API-DMAC7.html)
KR (1) KR102232221B1 (cg-RX-API-DMAC7.html)
CN (2) CN105143207B (cg-RX-API-DMAC7.html)
AU (2) AU2014241430B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015022474B1 (cg-RX-API-DMAC7.html)
CA (1) CA2895209C (cg-RX-API-DMAC7.html)
DK (1) DK3345902T3 (cg-RX-API-DMAC7.html)
ES (1) ES2769181T3 (cg-RX-API-DMAC7.html)
IL (1) IL240804B (cg-RX-API-DMAC7.html)
MX (1) MX370188B (cg-RX-API-DMAC7.html)
NZ (1) NZ711587A (cg-RX-API-DMAC7.html)
RU (1) RU2668073C2 (cg-RX-API-DMAC7.html)
SG (2) SG11201504709PA (cg-RX-API-DMAC7.html)
TW (2) TWI672292B (cg-RX-API-DMAC7.html)
WO (1) WO2014158998A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2668073C2 (ru) 2013-03-14 2018-09-26 Дарт Нейросайенс (Кайман) Лтд. Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4
EP3519816A4 (en) 2016-09-29 2020-05-06 The Regents of the University of California Compounds for increasing neural plasticity
CA3135420A1 (en) * 2018-04-05 2019-10-10 Universiteit Hasselt Selective pde4d inhibitors against demyelinating diseases
CN109438434B (zh) * 2018-11-19 2021-05-04 华南农业大学 一种含噁唑环的2-氰基亚氨基噻唑烷类化合物及其制备方法和应用
EP3930708A4 (en) 2019-02-27 2023-02-15 The Regents Of The University Of California N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR THE TREATMENT OF BRAIN DISORDERS
BR112021016620A2 (pt) 2019-02-27 2021-11-03 Univ California Azepino-indóis e outros heterociclos para o tratamento de distúrbios cerebrais
EP3959203A1 (en) * 2019-04-23 2022-03-02 Tetra Discovery Partners, Inc. 3-hydroxy-2-phenyl-6-(pyrazol-4-ylmethyl)pyridine derivatives as pde4d inhibitors
KR20220005559A (ko) * 2019-05-06 2022-01-13 칼시메디카, 인크 Crac 채널 억제제의 합성
PT3873883T (pt) * 2019-11-07 2023-03-24 Small Pharma Ltd Método de síntese
CN111995585B (zh) * 2020-08-04 2022-01-25 常州大学 嘧啶乙酰胺类化合物及其作为磷酸二酯酶pde2活性抑制剂的应用
US12404265B2 (en) 2020-08-04 2025-09-02 Nura Bio, Inc. Substituted pyridine derivatives as SARM1 inhibitors
CN116438171A (zh) 2020-09-16 2023-07-14 努拉生物公司 作为sarm1抑制剂的取代的吡啶衍生物
CA3226869A1 (en) 2021-07-28 2023-02-02 Rao Kolluri Substituted pyridine derivatives as sarm1 inhibitors
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
CN116265440B (zh) * 2021-12-16 2024-09-27 贵州大学 一种水杨酮拼接吡啶酮类化合物及其制备方法及应用
EP4562001A1 (en) * 2022-07-27 2025-06-04 Nura Bio, Inc. Substituted pyridine derivatives as sarm1 inhibitors
EP4596554A4 (en) 2022-09-29 2025-12-10 Suzhou Arkbiopharmaceutical Co Ltd Fused AZA Cyclic Compound, its Preparation Process and its Use in Medicine
CN116082254B (zh) * 2022-12-28 2025-04-11 浙江永太科技股份有限公司 一种1-烷基-1,2,4-三氮唑-3-甲醇的制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO1999031062A1 (en) 1997-12-17 1999-06-24 Shionogi & Co., Ltd. Novel pyridine compounds
US7868015B2 (en) 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
US9931318B2 (en) 2003-04-08 2018-04-03 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
AU2001284792A1 (en) 2000-08-10 2002-02-25 Cold Spring Harbor Laboratory Augmented cognitive training
GB0111078D0 (en) 2001-05-04 2001-06-27 Novartis Ag Organic compounds
AR037517A1 (es) 2001-11-05 2004-11-17 Novartis Ag Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
AR037714A1 (es) 2001-12-06 2004-12-01 Maxia Pharmaceuticals Inc Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer
CN100513397C (zh) 2002-11-19 2009-07-15 记忆药物公司 磷酸二酯酶4抑制剂
GB0229281D0 (en) 2002-12-16 2003-01-22 Novartis Ag Organic compounds
US20050020587A1 (en) 2003-07-25 2005-01-27 Pfizer Inc Nicotinamide derivatives useful as PDE4 inhibitors
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
KR101267392B1 (ko) * 2004-06-30 2013-05-23 주식회사 씨앤드씨신약연구소 피리딘 유도체 및 그의 제조방법
GB0425572D0 (en) 2004-11-19 2004-12-22 Glaxo Group Ltd 1,7-Naphthyridines
AU2006237354B2 (en) 2005-04-21 2012-03-01 Boehringer Ingelheim International Gmbh Dihydrothienopyrimidines for the treatment of inflammatory diseases
WO2006124874A2 (en) * 2005-05-12 2006-11-23 Kalypsys, Inc. Inhibitors of b-raf kinase
NZ570844A (en) 2006-02-28 2011-11-25 Helicon Therapeutics Inc Therapeutic piperazines as PDE4 inhibitors
JP5503874B2 (ja) 2006-02-28 2014-05-28 ダート ニューロサイエンス (ケイマン) エルティーディー 治療化合物
WO2007123953A2 (en) * 2006-04-19 2007-11-01 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
EP2032585B1 (de) 2006-05-24 2014-07-23 Boehringer Ingelheim International GmbH Substituierte pteridine als therapeutika
MX2009003222A (es) * 2006-10-04 2009-04-06 Hoffmann La Roche Derivados de 3-piridinocarboxamida y 2-pirazinocarboxamida como agentes elevadores de colesterol de lipoproteina de alta densidad.
BRPI0811623A2 (pt) 2007-05-15 2014-11-11 Helicon Therapeutics Inc Métodos para identificar genes envolvidos na formação de memória usando pequeno rna interferente (sirna)
KR101669432B1 (ko) 2007-08-27 2016-10-26 다트 뉴로사이언스 (케이만) 엘티디. 치료적 이속사졸 화합물
WO2009067618A1 (en) 2007-11-21 2009-05-28 Decode Genetics Ehf Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
AU2008326381B2 (en) * 2007-11-21 2014-10-23 Decode Genetics Ehf Biaryl PDE4 inhibitors for treating inflammation
US8877816B2 (en) 2007-11-21 2014-11-04 Decode Genetics Ehf 4-(or 5-) substituted catechol derivatives
KR20100108346A (ko) 2007-11-21 2010-10-06 디코드 제네틱스 이에이치에프 폐 및 심장혈관 질병의 치료를 위한 바이아릴 pde4 억제제
US20100029689A1 (en) 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20100125087A1 (en) 2008-11-14 2010-05-20 Astrazeneca Ab New compounds 575
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
JP2013540145A (ja) * 2010-10-21 2013-10-31 ウニベルシテート デス ザールランデス コルチゾール依存性疾患の治療用の選択的cyp11b1阻害剤
RU2668073C2 (ru) 2013-03-14 2018-09-26 Дарт Нейросайенс (Кайман) Лтд. Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4

Similar Documents

Publication Publication Date Title
JP2016512259A5 (cg-RX-API-DMAC7.html)
RU2015137615A (ru) Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4
JP2014528446A5 (cg-RX-API-DMAC7.html)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2007523182A5 (cg-RX-API-DMAC7.html)
RU2372347C2 (ru) Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2017500364A5 (cg-RX-API-DMAC7.html)
DK2491038T3 (da) Disubstituerede octahydropyrrolo [3,4-c]pyrroler som orexin receptormodulatorer
JP2019504854A5 (cg-RX-API-DMAC7.html)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
JP2018524331A5 (cg-RX-API-DMAC7.html)
JP2013508403A5 (cg-RX-API-DMAC7.html)
JP2013518046A5 (cg-RX-API-DMAC7.html)
HRP20220096T1 (hr) Inhibitori lizin specifične demetilaze-1
JP2018535999A5 (cg-RX-API-DMAC7.html)
JP2016519096A5 (cg-RX-API-DMAC7.html)
JP2016514718A5 (cg-RX-API-DMAC7.html)
JP2014531465A5 (cg-RX-API-DMAC7.html)
JP2015514072A5 (cg-RX-API-DMAC7.html)
JP2017502049A5 (cg-RX-API-DMAC7.html)
JP2014518214A5 (cg-RX-API-DMAC7.html)
RU2012133475A (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
JP2015528022A5 (cg-RX-API-DMAC7.html)
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
SI2763982T1 (en) Substituted benzylindazoles for use as inhibitors of Bub kinase in the treatment of hyperproliferative diseases